Literature DB >> 15967205

Effect of chronic intake of arsenic-contaminated water on liver.

D N Guha Mazumder1.   

Abstract

The hepatotoxic effect of arsenic when used in therapeutic dose has long been recognized. We described the nature and degree of liver involvement and its pathogenesis due to prolonged drinking of arsenic-contaminated water in West Bengal, India. From hospital-based studies on 248 cases of arsenicosis, hepatomegaly was found in 190 patients (76.6%). Non cirrhotic portal fibrosis was the predominant lesions in 63 out of 69 cases who underwent liver biopsy. The portal fibrosis was characterized by expansion of portal zones with streaky fibrosis, a few of which contained leash of vessels. However, portal hypertension was found in smaller number of cases. A cross-sectional epidemiological study was carried out on 7683 people residing in arsenic-affected districts of West Bengal. Out of these, 3467 and 4216 people consumed water-containing arsenic below and above 0.05 mg/l, respectively. Prevalence of hepatomegaly was significantly higher in arsenic-exposed people (10.2%) compared to controls (2.99%, P < 0.001). The incidence of hepatomegaly was found to have a linear relationship proportionate to increasing exposure of arsenic in drinking water in both sexes (P < 0.001). In an experimental study, BALB/C mice were given water contaminated with arsenic (3.2 mg/l) ad libitum for 15 months, the animals being sacrificed at 3-month intervals. We observed progressive reduction of hepatic glutathione and enzymes of anti-oxidative defense system associated with lipid peroxidation. Liver histology showed fatty infiltration at 12 months and hepatic fibrosis at 15 months. Our studies show that prolong drinking of arsenic-contaminated water is associated with hepatomegaly. Predominant lesion of hepatic fibrosis appears to be caused by arsenic induced oxystress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967205     DOI: 10.1016/j.taap.2004.08.025

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  78 in total

Review 1.  State of the science review of the health effects of inorganic arsenic: Perspectives for future research.

Authors:  Paul B Tchounwou; Clement G Yedjou; Udensi K Udensi; Maricica Pacurari; Jacqueline J Stevens; Anita K Patlolla; Felicite Noubissi; Sanjay Kumar
Journal:  Environ Toxicol       Date:  2018-12-04       Impact factor: 4.119

2.  Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.

Authors:  C E Eapen; Peter Nightingale; Stefan G Hubscher; Peter J Lane; Timothy Plant; Dimitris Velissaris; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

Review 3.  Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis.

Authors:  Jason Brocato; Max Costa
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

4.  Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.

Authors:  Xiang Zhang; Walter H Watson; Xue Shi; Xiaoli Wei; Imhoi Koo; Robin H Schmidt; Xinmin Yin; Seong Ho Kim; Andrew Vaughn; Craig J McClain; Gavin E Arteel
Journal:  J Proteome Res       Date:  2013-12-17       Impact factor: 4.466

5.  Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain.

Authors:  Maria Grau-Perez; Ana Navas-Acien; Inmaculada Galan-Chilet; Laisa S Briongos-Figuero; David Morchon-Simon; Jose D Bermudez; Ciprian M Crainiceanu; Griselda de Marco; Pilar Rentero-Garrido; Tamara Garcia-Barrera; Jose L Gomez-Ariza; Jose A Casasnovas; Juan C Martin-Escudero; Josep Redon; F Javier Chaves; Maria Tellez-Plaza
Journal:  Environ Pollut       Date:  2018-02-21       Impact factor: 8.071

6.  Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response.

Authors:  Lisa Smeester; Paige A Bommarito; Elizabeth M Martin; Rogelio Recio-Vega; Tania Gonzalez-Cortes; Edgar Olivas-Calderon; R Clark Lantz; Rebecca C Fry
Journal:  Environ Toxicol Pharmacol       Date:  2017-04-08       Impact factor: 4.860

7.  Arsenic and benzo[a]pyrene co-exposure acts synergistically in inducing cancer stem cell-like property and tumorigenesis by epigenetically down-regulating SOCS3 expression.

Authors:  Zhishan Wang; Ping Yang; Jie Xie; Hsuan-Pei Lin; Kazuyoshi Kumagai; Jack Harkema; Chengfeng Yang
Journal:  Environ Int       Date:  2020-02-18       Impact factor: 9.621

8.  Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.

Authors:  Jie Liu; Limei Yu; Erik J Tokar; Carl Bortner; Maria I Sifre; Yang Sun; Michael P Waalkes
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

10.  Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats.

Authors:  Swaran J S Flora; Swapnila Chouhan; Gurusamy M Kannan; Megha Mittal; Harimohan Swarnkar
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.